University of Leeds
Modelling plasma cell differentiation to risk stratify secondary antibody deficiencies for immunoglobulin replacement therapy
Abstract
dc:description.abstractB-cells of patients with secondary and primary antibody deficiency often exhibit defects in maturation, activation, or survival, which may lead to impaired immune responses after SARS-CoV-2 vaccination. These defects contribute to vaccine non- responsiveness in some patients. The underlying mechanisms and the feasibility of pre-vaccination risk stratification remain unclear. To investigate B-cell intrinsic differentiation capacities in a heterogeneous cohort of vaccine-responding and non- responding antibody-deficient patients, an in vitro plasma cell differentiation model has been utilised. Such an approach may also be useful in assessing their suitability for immunoglobulin replacement therapy (IgRT). B-cells from participants enrolled in the COV-AD study, taken after their fourth SARS-CoV-2 vaccine dose, were isolated and induced to differentiate into plasma cells. B-cell functionality at critical differentiation stages was assessed using flow cytometry, ELISA, BCR analysis, and RNA sequencing. The study revealed distinct differences in B-cell differentiation between vaccine responders and non-responders. Non-responders (n=15) and a subset of responders (n=10/35) exhibited significantly reduced or absent expression of the BAFF-R survival receptor. Immunoglobulin heavy chain sequencing showed no significant differences in BCR profiles between responders and non-responders. Both patient groups displayed reduced intracellular and secreted IgG and IgA expression compared to healthy controls. Atypical B-cell differentiation profiles in antibody deficient patients, particularly reduced BAFF-R expression, may underpin impaired SARS-CoV-2 vaccine responses. The identification of BAFF-R as a critical survival receptor emphasises its potential as a biomarker for risk stratification. Integrating BAFF-R profiling into clinical workflows could help identify patients at risk of poor immune outcomes, enabling tailored therapeutic interventions. Refining this in vitro plasma cell differentiation model to allow for faster assessments, focusing on BAFF-R levels and other key markers, will enhance its feasibility as a practical tool for pre-IgRT risk stratification in clinical settings.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Leeds
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- O'Callaghan, Eleanor Rose
- Advisors dc:contributor.advisor
-
- Savic, Sinisa
- Doody, Gina
Rights
- Language dc:language.dcterms_iso639_2
- eng